SCHEMBL741671

SCHEMBL741671

CCOC(=O)n1nc(NC(=O)c2ccc(N3CCN(C)CC3)cc2)c2cc(C(=O)OC(C)(C)C)sc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AURKA O14965 8/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
BTK Q06187 2/20 0.43
FLT3 P36888 2/20 0.43
KDR P35968 1/20 0.43
ABL1 P00519 1/20 0.42
BCR P11274 1/20 0.42
KIT P10721 1/20 0.42
PDE7A Q13946 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
NTRK1 P04629 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739309 0.92 CSNK1D (0.45) MEN1KMT2ABTKPDE7ANPC1
SCHEMBL740536 0.90 AURKA (0.46) AURKAFLT3KDRABL1BCR
Hydrochloric Acid SCHEMBL741106 0.89 AURKA (0.47) AURKAMEN1KMT2ABTKFLT3
SCHEMBL740739 0.89 IKBKE (0.42) BTKFLT3KDRABL1BCR
Hydrochloric Acid SCHEMBL5981340 0.88 CSNK1D (0.42) AURKAMEN1KMT2ABTKPDE7A
SCHEMBL1777894 0.88 ALK (0.43) AURKAMEN1KMT2ABTKPDE7A
SCHEMBL5981101 0.87 AURKA (0.44) AURKAFLT3KDRABL1BCR
SCHEMBL740459 0.86 FLT3 (0.42) MEN1KMT2AFLT3KDRKIT
SCHEMBL1781045 0.86 SIRT6 (0.42) BTKPDE7AMAPT
SCHEMBL742441 0.85 ADORA2A (0.46) KMT2APDE7AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481584-B2 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-07-09 US disclosed
US-20120165311-A1 1H-THIENO[2,3-C]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-28 US disclosed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed
EP-1711177-B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS PFIZER ITALIA SRL (IT) 2008-05-28 EP disclosed
EP-1711177-A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS Pfizer Italia S.r.l. (IT) 2006-10-18 EP disclosed
US-20050187209-A1 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2005-08-25 US disclosed
WO-2005074922-A1 1H-THIENO[2,3-c]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS PFIZER ITALIA S.R.L. (IT) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165311-A1 1H-THIENO[2,3-C]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS MAP3K19, MAP3K1, MAP3K3 AURKA 349/4885MEN1 2996/4885KMT2A 1578/4885
US-20050187209-A1 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors MAP3K19, MAP3K1, MAP3K3 AURKA 340/4885MEN1 2954/4885KMT2A 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.